Literature DB >> 9753319

Tumor induction of VEGF promoter activity in stromal cells.

D Fukumura1, R Xavier, T Sugiura, Y Chen, E C Park, N Lu, M Selig, G Nielsen, T Taksir, R K Jain, B Seed.   

Abstract

We have established a line of transgenic mice expressing the A. victoria green fluorescent protein (GFP) under the control of the promoter for vascular endothelial growth factor (VEGF). Mice bearing the transgene show green cellular fluorescence around the healing margins and throughout the granulation tissue of superficial ulcerative wounds. Implantation of solid tumors in the transgenic mice leads to an accumulation of green fluorescence resulting from tumor induction of host VEGF promoter activity. With time, the fluorescent cells invade the tumor and can be seen throughout the tumor mass. Spontaneous mammary tumors induced by oncogene expression in the VEGF-GFP mouse show strong stromal, but not tumor, expression of GFP. In both wound and tumor models the predominant GFP-positive cells are fibroblasts. The finding that the VEGF promoter of nontransformed cells is strongly activated by the tumor microenvironment points to a need to analyze and understand stromal cell collaboration in tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753319     DOI: 10.1016/s0092-8674(00)81731-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  272 in total

1.  Is cyclooxygenase-2 the alpha and the omega in cancer?

Authors:  S M Prescott
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 2.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

3.  VEGF expression by epithelial and stromal cell compartments: resolving a controversy.

Authors:  D R Senger; L Van De Water
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

5.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.

Authors:  Alexei A Bogdanov; Charles P Lin; Maria Simonova; Lars Matuszewski; Ralph Weissleder
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

Review 6.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 7.  Use of reporter genes for optical measurements of neoplastic disease in vivo.

Authors:  C H Contag; D Jenkins; P R Contag; R S Negrin
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

8.  Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.

Authors:  A Jacobs; M Dubrovin; J Hewett; M Sena-Esteves; C W Tan; M Slack; M Sadelain; X O Breakefield; J G Tjuvajev
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 9.  Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

Authors:  S A Kono; L E Heasley; R C Doebele; D R Camidge
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

10.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.